Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

53.50
BATS BZX Real-Time Price
As of 3:47pm ET
 +0.61 / +1.15%
Today’s Change
45.45
Today|||52-Week Range
71.60
-9.69%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for AbbVie have a median target of 73.00, with a high estimate of 85.00 and a low estimate of 56.00. The median estimate represents a +36.45% increase from the last price of 53.50.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.13
Sales
$6.0B
Reporting Date
Apr 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.25%
 
 
 
 
 
 
Growthannually 17.01%
 
 
 
 
 
 

Sales

Growthquarterly -5.50%
 
 
 
 
 
 
Growthannually 13.87%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.